These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22204481

  • 1. Translocator protein as a promising target for novel anxiolytics.
    Costa B, Da Pozzo E, Martini C.
    Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L, Bauer A, Melchner D, Hallof-Buestrich H, Stoertebecker P, Haen E, Kreutz M, Sarubin N, Milenkovic VM, Wetzel CH, Rupprecht R, Nothdurfter C.
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
    Bader S, Wolf L, Milenkovic VM, Gruber M, Nothdurfter C, Rupprecht R, Wetzel CH.
    Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C, Baghai TC, Schüle C, Rupprecht R.
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173.
    Costa B, Da Pozzo E, Cavallini C, Taliani S, Da Settimo F, Martini C.
    ACS Chem Neurosci; 2016 Aug 17; 7(8):1041-6. PubMed ID: 27385308
    [Abstract] [Full Text] [Related]

  • 11. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S, Pugliesi I, Da Settimo F.
    Curr Top Med Chem; 2011 Aug 17; 11(7):860-86. PubMed ID: 21291396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Translocator protein (TSPO) and neurosteroids: implications in psychiatric disorders.
    Da Pozzo E, Costa B, Martini C.
    Curr Mol Med; 2012 May 17; 12(4):426-42. PubMed ID: 22348611
    [Abstract] [Full Text] [Related]

  • 15. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E, Robello M, Costa B, Da Pozzo E, Baglini E, Salerno S, Da Settimo F, Martini C, Taliani S.
    Eur J Med Chem; 2021 Jan 01; 209():112924. PubMed ID: 33081988
    [Abstract] [Full Text] [Related]

  • 16. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK, Zhang LM, Zhao N, Chen HX, Zhang YZ, Liu YQ, Mi TY, Zhou WW, Li Y, Yang RF, Xu JP, Li YF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():40-6. PubMed ID: 23624119
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J, Schumacher M, Neumann ID.
    Mol Psychiatry; 2022 Jul 01; 27(7):2918-2926. PubMed ID: 35444254
    [Abstract] [Full Text] [Related]

  • 19. Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons.
    Barron AM, Higuchi M, Hattori S, Kito S, Suhara T, Ji B.
    Mol Neurobiol; 2021 Feb 01; 58(2):550-563. PubMed ID: 32989676
    [Abstract] [Full Text] [Related]

  • 20. Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects.
    Rupprecht R, Rammes G, Eser D, Baghai TC, Schüle C, Nothdurfter C, Troxler T, Gentsch C, Kalkman HO, Chaperon F, Uzunov V, McAllister KH, Bertaina-Anglade V, La Rochelle CD, Tuerck D, Floesser A, Kiese B, Schumacher M, Landgraf R, Holsboer F, Kucher K.
    Science; 2009 Jul 24; 325(5939):490-3. PubMed ID: 19541954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.